- Home
- FGBI vs KRRO Comparison
FGBI vs KRRO Comparison
Compare FGBI & KRRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGBI
- KRRO
- Stock Information
- Founded
- FGBI 1934
- KRRO 2014
- Country
- FGBI United States
- KRRO United States
- Employees
- FGBI N/A
- KRRO N/A
- Industry
- FGBI Savings Institutions
- KRRO Biotechnology: Pharmaceutical Preparations
- Sector
- FGBI Finance
- KRRO Health Care
- Exchange
- FGBI Nasdaq
- KRRO Nasdaq
- Market Cap
- FGBI 135.7M
- KRRO 125.4M
- IPO Year
- FGBI N/A
- KRRO 2019
- Fundamental
- Price
- FGBI $8.10
- KRRO $13.85
- Analyst Decision
- FGBI
- KRRO Strong Buy
- Analyst Count
- FGBI 0
- KRRO 7
- Target Price
- FGBI N/A
- KRRO $85.67
- AVG Volume (30 Days)
- FGBI 6.0K
- KRRO 126.6K
- Earning Date
- FGBI 08-12-2025
- KRRO 08-12-2025
- Dividend Yield
- FGBI 0.50%
- KRRO N/A
- EPS Growth
- FGBI N/A
- KRRO N/A
- EPS
- FGBI 0.13
- KRRO N/A
- Revenue
- FGBI $81,247,000.00
- KRRO $4,821,000.00
- Revenue This Year
- FGBI N/A
- KRRO $65.08
- Revenue Next Year
- FGBI $3.38
- KRRO N/A
- P/E Ratio
- FGBI $61.27
- KRRO N/A
- Revenue Growth
- FGBI N/A
- KRRO N/A
- 52 Week Low
- FGBI $6.56
- KRRO $10.29
- 52 Week High
- FGBI $15.25
- KRRO $98.00
- Technical
- Relative Strength Index (RSI)
- FGBI 38.91
- KRRO 47.77
- Support Level
- FGBI $8.50
- KRRO $14.75
- Resistance Level
- FGBI $9.18
- KRRO $16.77
- Average True Range (ATR)
- FGBI 0.33
- KRRO 1.47
- MACD
- FGBI -0.04
- KRRO 0.03
- Stochastic Oscillator
- FGBI 0.00
- KRRO 25.23
About FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.